Hisashi Oshiro

Papers

Total Citations

H-Index

About

Dr. Hisashi Oshiro is a leading urologic oncologist whose research centers on prostate cancer prognosis and treatment optimization, with a particular focus on post-surgical outcomes. His most-cited work investigates the critical role of cribriform pattern histology as a predictive factor for prostate-specific antigen (PSA) recurrence in patients undergoing salvage radiotherapy after prostatectomy. This study, published in 2024, addresses a pressing clinical challenge: despite the widespread adoption of robotic total prostatectomy, PSA recurrence remains a significant concern, and identifying reliable biomarkers to guide salvage radiotherapy decisions is essential. Dr. Oshiro’s findings demonstrate that the presence of cribriform architecture independently predicts poorer radiotherapy response, offering clinicians a histopathologic tool to stratify patient risk and tailor adjuvant treatment strategies. While early in its citation trajectory, this work has already garnered attention for its practical implications in precision oncology. Dr. Oshiro’s research bridges surgical pathology and radiation oncology, providing actionable insights that may reduce overtreatment and improve recurrence-free survival. His contributions underscore the importance of integrating detailed histologic patterns into post-prostatectomy management algorithms, positioning him as a rising voice in evidence-based urologic cancer care.